Shanghai AbelZeta Ltd. (China)

Homepage: abelzeta.com

Alternate names: Cellular Biomedicine Group (Shanghai) Ltd., Shanghai AbelZeta, Shanghai AbelZeta Ltd., Shanghai Cellular Biopharmaceutical Group Ltd.

ROR: 03rtc2j62

OpenAlex ID: I4405267658

Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus

2016 · Feifei Zhang, Lingling Wu, et al. · Journal of Autoimmunity · 291

Human Adipose-Derived Mesenchymal Stem Cells for Osteoarthritis: A Pilot Study with Long-Term Follow-Up and Repeated Injections

2018 · Yang Song, Hui Du, et al. · Regenerative Medicine · 276

Preclinical efficacy and clinical safety of clinical‐grade nebulized allogenic adipose mesenchymal stromal cells‐derived extracellular vesicles

2021 · Meng‐meng Shi, Qing‐yuan Yang, et al. · Journal of Extracellular Vesicles · 232

PDF

Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells‐derived exosomes in patients with mild to moderate Alzheimer’s disease: a phase I/II clinical trial

2023 · Xinyi Xie, Qingxiang Song, et al. · General Psychiatry · 203

PDF

Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study

2022 · Ying-Gang Zhu, Meng-meng Shi, et al. · Stem Cell Research & Therapy · 201

Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy

2016 · Weiguo Zhang, Jian-Hua Mao, et al. · Nature Communications · 198

PDF

ADSCs-derived extracellular vesicles alleviate neuronal damage, promote neurogenesis and rescue memory loss in mice with Alzheimer's disease

2020 · Xinyi Ma, Meng Huang, et al. · Journal of Controlled Release · 166

PDF

In vivo human adipose-derived mesenchymal stem cell tracking after intra-articular delivery in a rat osteoarthritis model

2016 · Meng Li, Xuan Luo, et al. · Stem Cell Research & Therapy · 119

PDF

Whole-genome sequencing reveals genomic signatures associated with the inflammatory microenvironments in Chinese NSCLC patients

2018 · Cheng Wang, Rong Yin, et al. · Nature Communications · 116

PDF

Large-sized bone defect repair by combining a decalcified bone matrix framework and bone regeneration units based on photo-crosslinkable osteogenic microgels

2021 · Junxiang Hao, Baoshuai Bai, et al. · Bioactive Materials · 105

Tailored Apoptotic Vesicle Delivery Platform for Inflammatory Regulation and Tissue Repair to Ameliorate Ischemic Stroke

2023 · Yang You, Jianpei Xu, et al. · ACS Nano · 82

Multi-compositional MRI evaluation of repair cartilage in knee osteoarthritis with treatment of allogeneic human adipose-derived mesenchymal progenitor cells

2019 · Xinxin Zhao, Jingjing Ruan, et al. · Stem Cell Research & Therapy · 74

PDF

Phase I study of C-CAR031, a GPC3-specific TGFβRIIDN armored autologous CAR-T, in patients with advanced hepatocellular carcinoma (HCC).

2024 · Qi Zhang, Qihan Fu, et al. · Journal of Clinical Oncology · 60

Comparative Proteomics Inspired Self‐Stimulated Release Hydrogel Reinforces the Therapeutic Effects of MSC‐EVs on Alzheimer's Disease

2023 · Meng Huang, Mengna Zheng, et al. · Advanced Materials · 52

PDF

Surface-tethered ROS-responsive micelle backpacks for boosting mesenchymal stem cell vitality and modulating inflammation in ischemic stroke treatment

2023 · Yang You, Yipu Liu, et al. · Journal of Controlled Release · 46

Phase 1 study of C-CAR088, a novel humanized anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma

2022 · Xiaoyan Qu, Gang An, et al. · Journal for ImmunoTherapy of Cancer · 34

PDF

Repair of Large-Scale Rib Defects Based on Steel-Reinforced Concrete-Designed Biomimetic 3D-Printed Scaffolds with Bone-Mineralized Microenvironments

2022 · Baoshuai Bai, Junxiang Hao, et al. · ACS Applied Materials & Interfaces · 33

Clinical application of a double-modified sulfated bacterial cellulose scaffold material loaded with FGFR2-modified adipose-derived stem cells in urethral reconstruction

2022 · Zhenpeng Zhu, Jiayu Yang, et al. · Stem Cell Research & Therapy · 29

PDF

A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma

2025 · Wenjuan Yu, Ping Li, et al. · Blood · 28

PDF

Manufacturing, quality control, and GLP-grade preclinical study of nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesicles

2024 · Jing Wang, Zhong-jin Chen, et al. · Stem Cell Research & Therapy · 26

PDF

Safety and efficacy of a novel anti-CD20 chimeric antigen receptor (CAR)-T cell therapy in relapsed/refractory (r/r) B-cell non-Hodgkin lymphoma (B-NHL) patients after failing CD19 CAR-T therapy.

2021 · Aibin Liang, Shiguang Ye, et al. · Journal of Clinical Oncology · 22

An Anti-Bcma CAR T-Cell Therapy (C-CAR088) Shows Promising Safety and Efficacy Profile in Relapsed or Refractory Multiple Myeloma

2020 · Gang An, Weiwei Sui, et al. · Blood · 22

Delivery of adipose-derived mesenchymal stem cells attenuates airway responsiveness and inflammation in a mouse model of ovalbumin-induced asthma.

2017 · Ranran Dai, Jia Liu, et al. · Europe PMC (PubMed Central) · 22

C-CAR039, a Novel Anti-CD20/CD19 Bi-Specific CAR T-Cell Therapy Shows Deep and Durable Clinical Benefits in Patients with Relapsed or Refractory (r/r) B-Cell Non-Hodgkin Lymphoma (B-NHL) in Long Term Follow up

2023 · Ping Li, Wen-Juan Yu, et al. · Blood · 20

Bioorthogonal microglia-inspired mesenchymal stem cell bioengineering system creates livable niches for enhancing ischemic stroke recovery via the hormesis

2023 · Jianpei Xu, Yinzhe Sun, et al. · Acta Pharmaceutica Sinica B · 13

Works count: 55

Citation count: 10,370